Cargando…

Estimation of virus-mediated cell fusion rate of SARS-CoV-2

Several viruses have the ability to form large multinucleated cells known as syncytia. Many properties of syncytia and the role they play in the evolution of a viral infection are not well understood. One basic question that has not yet been answered is how quickly syncytia form. We use a novel math...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amidei, Ava, Dobrovolny, Hana M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449781/ https://www.ncbi.nlm.nih.gov/pubmed/36088794 http://dx.doi.org/10.1016/j.virol.2022.08.016

Ejemplares similares

Estimation of viral kinetics model parameters in young and aged SARS-CoV-2 infected macaques
por: Rodriguez, Thalia, et al.
Publicado: (2021)

Modeling the role of asymptomatics in infection spread with application to SARS-CoV-2
por: Dobrovolny, Hana M.
Publicado: (2020)

Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Dobrovolny, Hana M.
Publicado: (2020)

Quantifying the effect of trypsin and elastase on in vitro SARS-CoV infections
por: Rodriguez, Thalia, et al.
Publicado: (2021)

Initial Inoculum and the Severity of COVID-19: A Mathematical Modeling Study of the Dose-Response of SARS-CoV-2 Infections
por: Fain, Baylor, et al.
Publicado: (2020)

Plant Alkaloids Inhibit Membrane Fusion Mediated by Calcium and Fragments of MERS-CoV and SARS-CoV/SARS-CoV-2 Fusion Peptides
por: Shekunov, Egor V., et al.
Publicado: (2021)

Estimating the cumulative rate of SARS-CoV-2 infection
por: Bollinger, Christopher R., et al.
Publicado: (2020)

Comparison of Cell Fusions Induced by Influenza Virus and SARS-CoV-2
por: Zhang, Chuyuan, et al.
Publicado: (2022)

SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation
por: Hörnich, Bojan F., et al.
Publicado: (2021)

The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation
por: Rajah, Maaran Michael, et al.
Publicado: (2022)

Five Antigen Tests for SARS-CoV-2: Virus Viability Matters
por: Homza, Miroslav, et al.
Publicado: (2021)

Cholesterol and Ceramide Facilitate Membrane Fusion Mediated by the Fusion Peptide of the SARS-CoV-2 Spike Protein
por: Niort, Kristina, et al.
Publicado: (2023)

Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture
por: Risner, Kenneth H., et al.
Publicado: (2022)

Impaired potency of neutralizing antibodies against cell–cell fusion mediated by SARS-CoV-2
por: Wang, Qian, et al.
Publicado: (2023)

The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects
por: Al-Salihi, Karima A., et al.
Publicado: (2021)

Estimating the burden of SARS-CoV-2 in France
por: Salje, Henrik, et al.
Publicado: (2020)

Alamandine: Potential Protective Effects in SARS-CoV-2 Patients
por: Soltani Hekmat, Ava, et al.
Publicado: (2021)

Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study
por: van Boven, Michiel, et al.
Publicado: (2023)

Quasi-Simpson paradox in estimating the expected mortality rate from the SARS-CoV-2
por: Shaki, Yair Y
Publicado: (2021)

The SARS-CoV-2 fusion domain preferentially initiates fusion in the late endosome
por: Birtles, Daniel, et al.
Publicado: (2023)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

Critical Negatively Charged Residues Are Important for the Activity of SARS-CoV-1 and SARS-CoV-2 Fusion Peptides
por: Lai, Alex L., et al.
Publicado: (2021)

SARS-CoV-2, the autoimmune virus
por: Halpert, Gilad, et al.
Publicado: (2020)

Is SARS-CoV-2 an oncogenic virus?
por: Gómez-Carballa, Alberto, et al.
Publicado: (2022)

Rates of Coinfection Between SARS-CoV-2 and Other Respiratory Viruses in Korea
por: Kim, Young-gon, et al.
Publicado: (2022)

Drug discovery targeting SARS-CoV-2 membrane fusion
por: Yang, Kailu, et al.
Publicado: (2023)

Cell‐mediated immunity to SARS‐CoV‐2
por: Wang, Xiaolin, et al.
Publicado: (2020)

SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection
por: Chaouat, Abigael Eva, et al.
Publicado: (2021)

Kaempferol inhibits SARS-CoV-2 invasion by impairing heptad repeats-mediated viral fusion
por: Gao, Junwei, et al.
Publicado: (2023)

Tropism of SARS-CoV-2, SARS-CoV, and Influenza Virus in Canine Tissue Explants
por: Bui, Christine H T, et al.
Publicado: (2021)

The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2
por: Pekar, Jonathan E., et al.
Publicado: (2023)

Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
por: Dong, Qunfeng, et al.
Publicado: (2020)

Data-driven case fatality rate estimation for the primary lineage of SARS-CoV-2 in Poland
por: Gogolewski, Krzysztof, et al.
Publicado: (2022)

Estimating generation time of SARS-CoV-2 variants in Italy from the daily incidence rate
por: Lippiello, Eugenio, et al.
Publicado: (2023)

Estimating the wave 1 and wave 2 infection fatality rates from SARS-CoV-2 in India
por: Purkayastha, Soumik, et al.
Publicado: (2021)

Assessing Uncertainty in A2 Respiratory Syncytial Virus Viral Dynamics
por: González-Parra, Gilberto, et al.
Publicado: (2015)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
por: Sada, Mitsuru, et al.
Publicado: (2020)

SARS-CoV-2 and influenza virus co-infection
por: Cuadrado-Payán, Elena, et al.
Publicado: (2020)

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
por: Chakraborty, Hirak, et al.
Publicado: (2020)

Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry
por: Sengar, Anjali, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vq18malh24r9iac89nppv3h2h8